Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics

Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics

Gene replacement therapy with oncosuppressor microRNAs (miRNAs) is a promising alternative to interfere with cancer progression. However, miRNAs are highly inefficient in a biological environment, hampering a successful translation to clinics. Nanotechnology can tackle this drawback by providing del...

Full description

Bibliographic Details
Main Authors:	Surasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, Maria de la Fuente
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Pharmaceutics
Subjects:	sphingomyelin nanomedicine gene therapy oncosuppressor mirnas colorectal cancer
Online Access:	https://www.mdpi.com/1999-4923/12/2/189

Similar Items

Diacylglycerol kinase ζ interacts with sphingomyelin synthase 1 and sphingomyelin synthase‐related protein via different regions
by: Masataka Furuta, et al.
Published: (2023-07-01)

Sphingomyelin metabolism controls the shape and function of the Golgi cisternae
by: Felix Campelo, et al.
Published: (2017-05-01)

Sphingomyelin-Rich Lipid Extract Collar for Canine Atopic Dermatitis
by: Sergi Segarra, et al.
Published: (2023-06-01)

Sphingomyelin is involved in regulating UCP1-mediated nonshivering thermogenesis
by: Detian Hu, et al.
Published: (2024-06-01)

The nutritional functions of dietary sphingomyelin and its applications in food
by: Fang Yang, et al.
Published: (2022-10-01)

Sphingomyelin metabolism underlies Ras excitability for efficient cell migration and chemotaxis
by: Da Young Shin, et al.
Published: (2023-07-01)

Engineered Lipidic Nanomaterials Inspired by Sphingomyelin Metabolism for Cancer Therapy
by: Han Zhu, et al.
Published: (2023-07-01)

Optimization of Giant Unilamellar Vesicle Electroformation for Phosphatidylcholine/Sphingomyelin/Cholesterol Ternary Mixtures
by: Zvonimir Boban, et al.
Published: (2022-05-01)

Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
by: Paul N. Jensen, et al.
Published: (2022-08-01)

Isolation and partial purification of a hemolytic sphingomyelin-inhibitable fraction from the sea anemone Anthopleura nigrescens
by: Javier Alvarado, et al.

Sphingomyelin is a prospective metabolic immune checkpoint for natural killer cells
by: Hongdi Ma, et al.
Published: (2023-09-01)

Pharmacological reversion of sphingomyelin‐induced dendritic spine anomalies in a Niemann Pick disease type A mouse model
by: Ana I Arroyo, et al.
Published: (2014-01-01)

Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells
by: Qi Zhou, et al.
Published: (2016-03-01)

Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19
by: Diana Mota Toro, et al.
Published: (2023-07-01)

PEGylation Effects on the Interaction of Sphingomyelin Nanoemulsions with Serum Albumin: A Thermodynamic Investigation
by: Daniela Gheorghe, et al.
Published: (2023-06-01)

Effects of Sphingomyelin-Containing Milk Phospholipids on Skin Hydration in UVB-Exposed Hairless Mice
by: Yejin Ahn, et al.
Published: (2022-04-01)

Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage
by: Shuhua He, et al.
Published: (2022-10-01)

Evolutionary conservation analysis of human sphingomyelin metabolism pathway genes
by: Siyuan Wang, et al.
Published: (2024-12-01)

The ORP9-ORP11 dimer promotes sphingomyelin synthesis
by: Birol Cabukusta, et al.
Published: (2024-08-01)

Sphingomyelins Prevent Propagation of Lipid Peroxidation—LC-MS/MS Evaluation of Inhibition Mechanisms
by: Giulia Coliva, et al.
Published: (2020-04-01)

Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
by: Elin Rebecka Carlsson, et al.
Published: (2018-04-01)

Enhanced In Vitro Expression of Filaggrin and Antimicrobial Peptides Following Application of Glycosaminoglycans and a Sphingomyelin-Rich Lipid Extract
by: Sergi Segarra, et al.
Published: (2022-06-01)

The interaction of milk sphingomyelin and proteins on stability and microstructure of dairy emulsions
by: Nahyun Ahn, et al.
Published: (2022-05-01)

Protective Role of Sphingomyelin in Eye Lens Cell Membrane Model against Oxidative Stress
by: Mehdi Ravandeh, et al.
Published: (2021-02-01)

Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
by: Tolulope Sokoya, et al.
Published: (2022-09-01)

Prospects for the use of statins in the treatment of neurofibromatosis type 1
by: R. N. Mustafin
Published: (2022-10-01)

Membrane Sphingomyelin in Host Cells Is Essential for Nucleocapsid Penetration into the Cytoplasm after Hemifusion during Rubella Virus Entry
by: Yoshio Mori, et al.
Published: (2022-12-01)

Sortase A-Cleavable CD1d Identifies Sphingomyelins as Major Class of CD1d-Associated Lipids
by: Maren Rudolph, et al.
Published: (2022-07-01)

Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis
by: Zainab Jahangir, et al.
Published: (2018-09-01)

The impacts of dietary sphingomyelin supplementation on metabolic parameters of healthy adults: a systematic review and meta-analysis of randomized controlled trials
by: Chen-Zi Li, et al.
Published: (2024-02-01)

The relationship among amyloid-β deposition, sphingomyelin level, and the expression and function of P-glycoprotein in Alzheimer’s disease pathological process
by: Zi-Kang Xing, et al.
Published: (2023-01-01)

The Effect of Cholesterol on the Long-Range Network of Interactions Established among Sea Anemone Sticholysin II Residues at the Water-Membrane Interface
by: Sara García-Linares, et al.
Published: (2015-03-01)

Inhibition of Circulating Exosomal miRNA-20b-5p Accelerates Diabetic Wound Repair [Retraction]
by: Chen K, et al.
Published: (2024-06-01)

Daurichromenic Acid from the Chinese Traditional Medicinal Plant <i>Rhododendron dauricum</i> Inhibits Sphingomyelin Synthase and Aβ Aggregation
by: Hadya Virupaksha Deepak, et al.
Published: (2020-09-01)

miRNA Delivery by Nanosystems: State of the Art and Perspectives
by: Fernanda C. Moraes, et al.
Published: (2021-11-01)

A non-toxic equinatoxin-II reveals the dynamics and distribution of sphingomyelin in the cytosolic leaflet of the plasma membrane
by: Toshiki Mori, et al.
Published: (2024-07-01)

Sphingomyelin Depletion from Plasma Membranes of Human Airway Epithelial Cells Completely Abrogates the Deleterious Actions of <em>S. aureus</em> Alpha-Toxin
by: Sabine Ziesemer, et al.
Published: (2019-02-01)

The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency
by: Monica Kumar, et al.
Published: (2024-01-01)

Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer
by: María Cascallar, et al.
Published: (2022-10-01)

Protein-based artificial nanosystems in cancer therapy
by: Zhang, Nan, et al.
Published: (2021)